Skip to main content

Advertisement

SpringerLink
Log in

Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

NAD(P)H: quinone oxidoreductase 1 (NQO1) is an important enzyme which can catalyze the two-electron reduction of quinoid compounds into hydroquinones. NQO1 Pro187Ser polymorphism can change the enzymatic activity of NQO1, and it has been proposed to be associated with risk of esophageal cancer. We performed a meta-analysis to examine the association between NQO1 Pro187Ser polymorphism and esophageal cancer. Odds ratio (OR) with a 95 % confidence interval (95 % CI) was used to assess the association. Twelve case–control studies with 1,725 cases with esophageal cancer and 2,341 controls were finally included in the meta-analysis. Overall, there was an obvious association between NQO1 Pro187Ser polymorphism and esophageal cancer (allele model: OR = 1.24, 95 % CI 1.06–1.46, P OR = 0.009; homozygote model: OR = 1.59, 1195 % CI 1.10–2.30, P OR = 0.013; dominant model: OR = 1.31, 95 % CI 1.05–1.64, P OR = 0.018). In the subgroup analysis by ethnicity, there was an obvious association between NQO1 Pro187Ser polymorphism and esophageal cancer in Asians but not in Caucasians. Therefore, the meta-analysis suggests that NQO1 Pro187Ser polymorphism is associated with esophageal cancer risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241–52.

    Article  PubMed  CAS  Google Scholar 

  2. Fitzgerald RC. Molecular basis of Barrett’s oesophagus and oesophageal adenocarcinoma. Gut. 2006;55:1810–20.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  3. Maley CC. Open questions in oesophageal adenocarcinogenesis. Gut. 2007;56:897–8.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  4. Lao-Sirieix P, Caldas C, Fitzgerald RC. Genetic predisposition to gastro-oesophageal cancer. Curr Opin Genet Dev. 2010;20:210–7.

    Article  PubMed  CAS  Google Scholar 

  5. Dinkova-Kostova AT, Talalay P. NAD(P)H:Quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch Biochem Biophys. 2010;501:116–23.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  6. Siegel D, Yan C, Ross D. NAD(P)H:Quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones. Biochem Pharmacol. 2012;83:1033–40.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  7. Guha N, Chang JS, Chokkalingam AP, Wiemels JL, Smith MT, Buffler PA. NQO1 polymorphisms and de novo childhood leukemia: a huge review and meta-analysis. Am J Epidemiol. 2008;168:1221–32.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Dougherty D, Garte S, Barchowsky A, Zmuda J, Taioli E. NQO1, MPO, CYP2E1, GSTT1 and GSTM1 polymorphisms and biological effects of benzene exposure—a literature review. Toxicol Lett. 2008;182:7–17.

    Article  PubMed  CAS  Google Scholar 

  9. Yang FY, Guan QK, Cui YH, Zhao ZQ, Rao W, Xi Z. NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: a meta-analysis based on 21 case–control studies. Eur J Cancer Prev. 2012;21:432–41.

    Article  PubMed  CAS  Google Scholar 

  10. Hamajima N, Matsuo K, Iwata H, Shinoda M, Yamamura Y, Kato T, et al. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Int J Clin Oncol. 2002;7:103–8.

    PubMed  CAS  Google Scholar 

  11. Zhang J, Schulz WA, Li Y, Wang R, Zotz R, Wen D, et al. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a german caucasian and a northern chinese population. Carcinogenesis. 2003;24:905–9.

    Article  PubMed  CAS  Google Scholar 

  12. Zhang JH, Li Y, Wang R, Sarbia M, Guo W, Wen DG, et al. The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003;20:544–6.

    PubMed  CAS  Google Scholar 

  13. von Rahden BH, Stein HJ, Langer R, von Weyhern CW, Schenk E, Doring C, et al. C609t polymorphism of the NAD(P)H: quinone oxidoreductase i gene does not significantly affect susceptibility for esophageal adenocarcinoma. Int J Cancer. 2005;113:506–8.

    Article  CAS  Google Scholar 

  14. Feng X, Li Z, Wang L, Zhang J, Lu Z. Study on the relationship between polymorphisms of NQO1 gene and susceptibility to esophageal cancer. Chinese journal of disease control & prevention. 2008;12:112–4.

    CAS  Google Scholar 

  15. Marjani HA, Biramijamal F, Rakhshani N, Hossein-Nezhad A, Malekzadeh R. Investigation of NQO1 genetic polymorphism, NQO1 gene expression and PAH-DNA adducts in ESCC. A case–control study from iran. Genet Mol Res. 2010;9:239–49.

    Article  PubMed  CAS  Google Scholar 

  16. Umar M, Upadhyay R, Kumar S, Ghoshal UC, Mittal B. Null association of NQO1 609C > T and NQO2-3423G > A polymorphisms with susceptibility and prognosis of esophageal cancer in north Indian population and meta-analysis. Cancer Epidemiol. 2012;36:e373–379.

    Article  PubMed  CAS  Google Scholar 

  17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    PubMed  CAS  Google Scholar 

  19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  PubMed  CAS  Google Scholar 

  20. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  21. Sarbia M, Bitzer M, Siegel D, Ross D, Schulz WA, Zotz RB, et al. Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract. Int J Cancer. 2003;107:381–6.

    Article  PubMed  CAS  Google Scholar 

  22. Zhang WC, Yin LH, Pu YP, Liang GY, Hu X, Liu YZ, et al. Relationship between quinone oxidoreductase1 gene ns-cSNP and genetic susceptibility of esophageal cancer. Zhonghua Yu Fang Yi Xue Za Zhi. 2006;40:324–7.

    PubMed  CAS  Google Scholar 

  23. Zhou Y, Chen H, Shi X, Zhou Z, Li G, Pan P, et al. A case–control study on the polymorphisms of NQO1 and susceptibility of esophageal cancer. Bulletin of Chinese cancer. 2006;15:659–63.

    CAS  Google Scholar 

  24. di Martino E, Hardie LJ, Wild CP, Gong YY, Olliver JR, Gough MD, et al. The NAD(P)H: quinone oxidoreductase i C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinoma. Genet Med. 2007;9:341–7.

    Article  PubMed  CAS  Google Scholar 

  25. Malik MA, Zargar SA, Mittal B. Role of NQO1 609C > T and NQO2-3423 G > A gene polymorphisms in esophageal cancer risk in Kashmir Valley and meta analysis. Mol Biol Rep. 2012;39:9095–104.

    Article  PubMed  CAS  Google Scholar 

  26. Lajin B, Alachkar A. The NQO1 polymorphism C609T (pro187ser) and cancer susceptibility: a comprehensive meta-analysis. Br J Cancer 2013. 2013. doi:10.1038/bjc.2013.357.

    Google Scholar 

  27. Wang Y, Zhang G, Luo Y. Association between NQO1 C609T polymorphism and colorectal cancer risk. Tumour Biol. 2013. doi:10.1007/s13277-013-0993-7.

    Google Scholar 

Download references

Conflicts of interests

None

Author information

Authors and Affiliations

  1. Department of Thoracic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, 315040, Zhejiang province, China

    Kai Liu, Hui Tian, Kai-Zhong Yu, Wei-Yu Shen, Zhen-Chun Mao, Chen-Hua Jin, Hai-Bin Pan & Jin-Xian He

Authors
  1. Kai Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hui Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kai-Zhong Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wei-Yu Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhen-Chun Mao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chen-Hua Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hai-Bin Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jin-Xian He
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hui Tian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, K., Tian, H., Yu, KZ. et al. Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis. Tumor Biol. 35, 2063–2068 (2014). https://doi.org/10.1007/s13277-013-1273-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1273-2

Keywords

Search

Navigation